Effects of the second-generation leukotriene B 4 receptor antagonist, LY293111Na, on leukocyte infiltration and collagen-induced arthritis in mice

By Kuwabara K.   Yasui K.   Jyoyama H.   Maruyama T.   Fleisch J.H.   Hori Y.  

European Journal of Pharmacology, Vol. 402, Iss. 3, 2000-08 ,pp. : 275-285

Elsevier

Access to resources Recommend Favorite

Combination of a cyclooxygenase-2 inhibitor with a leukotriene B₄ receptor antagonist

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 7, 1997-07 ,pp. : 765-766

Informa Healthcare

Access to resources Recommend Favorite

Comparative effects of a glucocorticosteroid, theophylline and the peptido-leukotriene-antagonist CGP 45715A on antigen-induced early and late phase airway response and inflammatory cell influx in sensitised guinea pigs

By Heuer H.O.   Leon I.   Anderson G.P.   Jennewein H.-M.  

European Journal of Pharmacology, Vol. 369, Iss. 2, 1999-03 ,pp. : 225-231

Elsevier

Access to resources Recommend Favorite

Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats

By Abdel-Raheem Ihab   Khedr Naglaa  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 387, Iss. 4, 2014-04 ,pp. : 341-353

Springer Publishing Company

Access to resources Recommend Favorite

The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C 4 in the guinea-pig ileum

By Back M.   Jonsson E.W.   Dahlen S.-E.  

European Journal of Pharmacology, Vol. 317, Iss. 1, 1996-12 ,pp. : 107-113

Elsevier

Access to resources Recommend Favorite